Connect Biopharma Holdings Limited Retained Earnings
Connect Biopharma Holdings Limited (CNTB) had Retained Earnings of -$437.52 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$437.52M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$420.23M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$400.83M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$385.73M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$437.52M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$420.23M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$400.83M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$385.73M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$368.53M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$355.63M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$345.36M 10-K · filed 2026-03-31 |
| 2023-12-31 | -$329.73M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |